{"id":17599,"date":"2026-03-24T15:55:58","date_gmt":"2026-03-24T15:55:58","guid":{"rendered":"https:\/\/aatworld.com\/?p=17599"},"modified":"2026-03-24T15:55:59","modified_gmt":"2026-03-24T15:55:59","slug":"microrobots-signal-next-medical-breakthrough","status":"publish","type":"post","link":"https:\/\/aatworld.com\/ar\/microrobots-signal-next-medical-breakthrough\/","title":{"rendered":"Microrobots Signal Next Medical Breakthrough"},"content":{"rendered":"<p class=\"has-text-align-left\"><strong>Microscopic medical robots are emerging as a breakthrough in biomedicine, with experts identifying in-vivo micro robotics as the next frontier after AI-driven drug development.<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-left\"><strong>Magnetically controlled, flexible devices can navigate the human body through minimally invasive entry points to perform tasks such as clot removal, tissue sampling, targeted drug delivery, and in-body imaging\u2014capabilities beyond conventional surgery.<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-left\"><strong>At this year\u2019s MEDTEX forum, micro robotics and AI drug discovery were highlighted as key themes. Industry leaders emphasized efforts to combine global innovation with Taiwan\u2019s engineering and clinical strengths to develop scalable medical technologies.<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-left\"><strong>Recent advances include ultra-flexible vascular robots capable of remote-controlled procedures, improving precision while reducing tissue damage. In 2025, the technology achieved a milestone with the first cross-continental remote thrombectomy trial.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Microscopic medical robots are emerging as a breakthrough in biomedicine, with experts identifying in-vivo micro robotics as the next frontier after AI-driven drug development. Magnetically controlled, flexible devices can navigate&hellip;<\/p>","protected":false},"author":1,"featured_media":17594,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[24,1],"tags":[],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/posts\/17599"}],"collection":[{"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/comments?post=17599"}],"version-history":[{"count":1,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/posts\/17599\/revisions"}],"predecessor-version":[{"id":17600,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/posts\/17599\/revisions\/17600"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/media\/17594"}],"wp:attachment":[{"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/media?parent=17599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/categories?post=17599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aatworld.com\/ar\/wp-json\/wp\/v2\/tags?post=17599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}